Numinus to Participate in Citi's Psychedelic Drug Call Series on February 2, 2022 Pharmaceutical Investing
Avricore Health CEO and Special Guests Join Radius Research for Investor Update Pharmaceutical Investing
 Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age Pharmaceutical Investing
FDA Approves Veklury® for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression Pharmaceutical Investing
U.S. FDA Approves Second Indication for SKYRIZI® to Treat Adults with Active Psoriatic Arthritis Pharmaceutical Investing
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency Pharmaceutical Investing
BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder Treatment With BETR-001 Pharmaceutical Investing
Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer Pharmaceutical Investing
